Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dansong Wang

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
BMC Geriatrics|July 3, 2025
Pancreatic surgery is safe in elderly patients with PDACYueming Zhang, Siyang Han, Yaolin Xu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 30, 2017
SF3B4 is decreased in pancreatic cancer and inhibits the growth and migration of cancer cellsWentao Zhou, Ning Ma, Hao Jiang, et al.
Cancer Medicine|July 24, 2022
Circulating cytokines allow for identification of malignant intraductal papillary mucinous neoplasms of the pancreasNing Pu, Qiangda Chen, Jicheng Zhang, et al.
Endocrine Connections|February 24, 2018
Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphologyXu Han, Xuefeng Xu, Hongyun Ma, et al.
Cell Death & Disease|October 31, 2021
Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancerHanlin Yin, Ning Pu, Qiangda Chen, et al.
Journal of Translational Medicine|October 26, 2018
CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancerNing Pu, Guochao Zhao, Hanlin Yin, et al.
Clinical and Experimental Medicine|January 24, 2019
TRAF6 regulates YAP signaling by promoting the ubiquitination and degradation of MST1 in pancreatic cancerJian-Ang Li, Tiantao Kuang, Ning Pu, et al.
Cell Cycle (Georgetown, Tex.)|November 22, 2017
Chk1 inhibitor SCH 900776 enhances the antitumor activity of MLN4924 on pancreatic cancerJian-Ang Li, Chao Song, Yefei Rong, et al.
Pancreas|July 26, 2017
One Hundred Twenty-One Resected Solid Pseudopapillary Tumors of the Pancreas: An 8-Year Single-Institution Experience at Zhongshan Hospital, Shanghai, ChinaYadong Xu, Guochao Zhao, Ning Pu, et al.
Frontiers in Oncology|August 3, 2023
Additional adjuvant radiotherapy improves survival at 1 year after surgical treatment for pancreatic cancer patients with T<sub>4</sub>, N<sub>2</sub> disease, positive resection margin, and receiving adjuvant chemotherapyLili Wu, Yaolin Xu, Yuhong Zhou, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
BMC Geriatrics|July 3, 2025
Pancreatic surgery is safe in elderly patients with PDACYueming Zhang, Siyang Han, Yaolin Xu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 30, 2017
SF3B4 is decreased in pancreatic cancer and inhibits the growth and migration of cancer cellsWentao Zhou, Ning Ma, Hao Jiang, et al.
Cancer Medicine|July 24, 2022
Circulating cytokines allow for identification of malignant intraductal papillary mucinous neoplasms of the pancreasNing Pu, Qiangda Chen, Jicheng Zhang, et al.
Endocrine Connections|February 24, 2018
Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphologyXu Han, Xuefeng Xu, Hongyun Ma, et al.
Cell Death & Disease|October 31, 2021
Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancerHanlin Yin, Ning Pu, Qiangda Chen, et al.
Journal of Translational Medicine|October 26, 2018
CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancerNing Pu, Guochao Zhao, Hanlin Yin, et al.
Clinical and Experimental Medicine|January 24, 2019
TRAF6 regulates YAP signaling by promoting the ubiquitination and degradation of MST1 in pancreatic cancerJian-Ang Li, Tiantao Kuang, Ning Pu, et al.
Cell Cycle (Georgetown, Tex.)|November 22, 2017
Chk1 inhibitor SCH 900776 enhances the antitumor activity of MLN4924 on pancreatic cancerJian-Ang Li, Chao Song, Yefei Rong, et al.
Pancreas|July 26, 2017
One Hundred Twenty-One Resected Solid Pseudopapillary Tumors of the Pancreas: An 8-Year Single-Institution Experience at Zhongshan Hospital, Shanghai, ChinaYadong Xu, Guochao Zhao, Ning Pu, et al.
Frontiers in Oncology|August 3, 2023
Additional adjuvant radiotherapy improves survival at 1 year after surgical treatment for pancreatic cancer patients with T<sub>4</sub>, N<sub>2</sub> disease, positive resection margin, and receiving adjuvant chemotherapyLili Wu, Yaolin Xu, Yuhong Zhou, et al.
Pageof 6